Additionally, ccRCC tumors have an increased expression of immune checkpoint molecules, such as programmed death-ligand 1 (PD-L1), which can inhibit T cell activation and promote tumor immune evasion [19,20]. The gene discussed is CD274; the disease is nonpapillary renal cell carcinoma.